Epithelial coating techniques in the treatment of interstitial cystitis

Urology

Volumn 49, Issue 5 SUPPL., 1997, Pages 100-104

  Parsons, C Lowell ^a  

^a UCSD MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSAMINOGLYCAN; HEPARIN; PENTOSAN POLYSULFATE;

ARTICLE; BLADDER FUNCTION; CELL MEMBRANE PERMEABILITY; CELL SURFACE; CLINICAL FEATURE; DISEASE ASSOCIATION; HUMAN; INTERSTITIAL CYSTITIS; PRIORITY JOURNAL; REMISSION; TREATMENT PLANNING;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYSTITIS, INTERSTITIAL; HEPARIN; HUMANS; PENTOSAN SULFURIC POLYESTER; PERMEABILITY; POTASSIUM CHLORIDE; UROTHELIUM;

EID: 0031001403     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00180-5     Document Type: Article

References (34)

1. Weaver RG, Dougherty RF, and Natoli C: Recent concepts of interstitial cystitis. J Urol 89: 377-383, 1963.
2. Parsons CL, Benson G, Childs SJ, Hanno P, Sant GR, and Webster G: A quantitatively controlled method to prospectively study interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate. J Urol 150: 845-848, 1993.
3. Parsons CL, Boychuk D, Jones S, Hurst R, and Callahan H: Bladder surface glycosaminoglycans: an epithelial permeability barrier. J Urol 143: 139-142, 1990.
4. Parsons CL, Housley T, Schmidt JD, and Lebow D: Treatment of interstitial cystitis with intravesical heparin. Br J Urol 73: 504-507, 1994.
5. Parsons CL, Lilly JD, and Stein P: Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis). J Urol 145: 732-735, 1991.
6. Parsons CL, Stein PC, Bidair M, and Lebow D: Abnormal sensitivity to intravesical potassium in interstitial cystitis and radiation cystitis. Neurourol Urodyn 13: 515-520, 1994.
7. Parsons CL: Prevention of urinary tract infection by the exogenous glycosaminoglycan sodium pentosanpolysulfate. J Urol 127: 167-169, 1982.
8. Hanno PM, Parsons CL, Shrom SH, Fritz R, and Mulholland SG: The protective effect of heparin in experimental bladder infection. J Surg Res 25: 324-329, 1978.
9. Parsons CL, Greenspan C, Moore SW, and Mulholland SG: Role of surface mucin in primary antibacterial defense of bladder. Urology 9: 48-52, 1977.
10. Parsons CL, Greenspan C, and Mulholland SG: The primary antibacterial defense mechanism of the bladder. Invest Urol 13: 72-78, 1975.
11. Parsons CL, Mulholland S, and Anwar H: Antibacterial activity of bladder surface mucin duplicated by exogenous glycosaminoglycan (heparin). Infect Immun 24: 552-557, 1979.
12. Parsons CL, Stauffer C, and Schmidt J: Bladder surface glycosaminoglycans: an efficient mechanism of environmental adaptation. Science 208: 605-607, 1980.
13. Gregor HP: Anticoagulant activity of sulfonate polymers and copolymers, in Gregor HP (Ed.): Polymer Science and Technology, Vol. 5. Plenum Press, New York, 1975, pp 51-56.
14. Gregor HP: Fixed charge ultrafiltration membranes, in Selegny E (Ed.): Charged Gels and Membranes, Part I. D. Reidel, Dordrecht, Holland, 1976, p 235.
15. Gryte CC, and Gregor HP: Poly-(styrene sulfonic acid)-poly-(vinylidene fluoride) interpolymer ion-exchange membranes. J Polymer Sci 14: 1839-1854, 1976.
16. Hurst RE: Thermodynamics of the partition of chondroitin sulfate-hexadecylpyridinium complexes in butanol/ aqueous salt biphasic solutions. Biopolymers 17: 2601-2608, 1978.
17. Hurst RE, Rhodes SW, Adamson PB, Parsons CL, and Roy JB: Functional and structural characteristics of the glycosaminoglycans of the bladder luminal surface. J Urol 138: 433-437, 1987.
18. Menter JM, Hurst RE, Nakamura N, and West SS: Thermodynamics of mucopolysaccharide-dye binding. III. Thermodynamic and cooperatively parameters of acridine orange-heparin system, Biopolymers 18: 493-505, 1979.
19. Cornish J, Nickel JC, Vanderwee M, and Costerton JW: Ultrastructural visualization of human bladder mucous. Urol Res 18: 263-266, 1990.
20. Lilly JD, and Parsons CL: Bladder surface glycosaminoglycans: a human epithelial permeability barrier. Surg Gynecol Obstet 171: 493-96, 1990.
21. 99mtechnetium-diethylenetriaminepentaacetic acid. J Urol 151: 346-9, 1994.
22. Parsons CL: Interstitial cystitis: clinical manifestations and diagnostic criteria in over 200 cases. Neurourol Urodyn 9: 241-50, 1990.
23. Lose G, Frandsen B, and Hojensgard JC, et al: Chronic interstitial cystitis: increased levels of eosinophil cationic protein in serum and urine and an ameliorating effect of subcutaneous heparin. Scand J Urol Nephrol 17(2): 159-161, 1983.
24. Parsons CL, and Mulholland S: Successful therapy of interstitial cystitis with pentosanpolysulfate. J Urol 138: 513-516, 1987
25. Parsons CL, Schmidt J, and Pollen J: Successful treatment of interstitial cystitis with sodium pentosanpolysulfate. J Urol 130: 51-53, 1983.
26. Mulholland SG, Hanno P, Parsons CL, Sant GR, and Staskin DR: Pentosan polysulfate sodium for therapy of interstitial cystitis: a double-blind placebo-controlled clinical study. Urology 35: 552-558, 1990.
27. Holm-Bentzen M, Jacobsen F, Nerstrom B, Lose G, Kristensen JK, Pedersen RH, Krarup T, Feggetter J, Bates P, and Barnard P et al: A prospective double-blind clinically controlled multicenter trial of sodium pentosanpolysulfate in the treatment of interstitial cystitis and related painful bladder disease. J Urol 138: 503-507, 1987.
28. Sant GR: Interstitial cystitis: Pathophysiology, clinical evaluation and treatment. Ann Urol 3: 172-179, 1989.
29. Sant GR, Kalaru P, and Ucci AA Jr: Mucosal mast cell (MMC) contribution to bladder mastocytosis in interstitial cystitis. J Urol 139: 276A, 1988.
30. Sant GR, and Theoharides TC: The role of the mast cell in interstitial cystitis. Urol Clin North Am 21: 41-53, 1994.
31. Bumpus HC: Interstitial cystitis. Med Clin North Am 13: 1495-1498, 1930.
32. Messing EM, and Stamey TA: Interstitial cystitis: early diagnosis, pathology, and treatment. Urology 12: 381-392, 1978.
33. Stewart BH, Persky L, and Kiser WS: The use of dimethylsulfoxide (DMSO) in the treatment of interstitial cystitis. J Urol 98: 671-672, 1967.
34. Morales A, Emerson L, Nickel JC, and Lundie M: Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. J Urol 156: 45-48, 1996.